Stratasys Ltd. reports developments in polymer 3D printing and additive manufacturing for industrial, dental, medical and product-design applications. Company updates commonly cover connected 3D printers, polymer materials, GrabCAD software, parts on demand through Stratasys Direct, and platform families that include FDM, PolyJet, P3 DLP and SLA technologies.
Recurring news also includes quarterly and annual financial results, conference-call materials, product and material launches, application expansion in aerospace, automotive, consumer products, healthcare and defense, and regulatory milestones such as European certification for TrueDent dental resins. The company also announces Form 20-F availability and other public-company reporting matters as a Nasdaq-listed foreign issuer.
Stratasys Ltd. (NASDAQ: SSYS) has expanded its healthcare services by launching a Healthcare Print Center in Eden Prairie, Minn., utilizing J750 Digital Anatomy printers. This facility enables the production of realistic 3D printed anatomical models for medical device manufacturers and healthcare providers. In just 13 weeks, Stratasys Direct has printed over 1,000 models for top medical device manufacturers, running each machine for over 120 hours weekly. Additionally, they provide comprehensive design and consulting services tailored to meet client needs.
Stratasys Ltd. (NASDAQ: SSYS) showcased advancements in additive manufacturing at the RAPID + TCT Show, emphasizing new materials and software partnerships. The company introduced new polymer 3D printing systems targeting mass production and launched the Origin Open Material License for enhanced material customization. With expanded material options like High-Yield PA11 and Dura56, Stratasys aims to enhance manufacturing efficiency. The GrabCAD Software Partner Program also expanded, integrating new partners to streamline production workflows in compliance with Industry 4.0.
Summary not available.
Stratasys Ltd. (NASDAQ: SSYS) reported strong second-quarter 2021 results with revenue reaching $147.0 million, a 25% increase from the previous year. GAAP gross margin improved to 43.0%, up from 37.2%. Operating losses decreased, with a GAAP loss of $22.7 million compared to $29.3 million last year. Non-GAAP net loss narrowed to $1.6 million, or $0.02 per diluted share. Adjusted EBITDA was $3.5 million, reflecting positive operational cash flow. The company anticipates 17% - 18% revenue growth in Q3 2021, emphasizing expansion in healthcare and manufacturing.
Stratasys Ltd (Nasdaq: SSYS) will announce its second quarter financial results for the period ending June 30, 2021, on August 5, 2021, at 8:30 a.m. (ET). Investors can join the conference call via live webcast or by telephone, with details provided for both options. Stratasys is recognized for its innovative 3D printing solutions catered to various industries including aerospace, automotive, and healthcare, aiming to enhance product design and manufacturing processes.
Stratasys Ltd. (NASDAQ: SSYS) announced the expansion of its GrabCAD Software Partner Program, now including Teton Simulation, enhancing its 3D printing solutions. The program aims to integrate advanced software applications with Stratasys' additive manufacturing technologies, improving production efficiency. Teton Simulation's SmartSlice application will optimize print parameters, ensuring better performance and reduced material waste. The company has now partnered with six firms since the program's inception, showcasing Stratasys' commitment to building a robust ecosystem for advanced manufacturing.
Stratasys Ltd. (NASDAQ: SSYS) has unveiled two innovative PolyJet 3D printers: the J35 Pro and J55 Prime, enhancing rapid prototyping capabilities in design and packaging. The J35 Pro is Stratasys' first multi-material desktop 3D printer, enabling the use of various materials for high-fidelity models. The J55 Prime expands options with new materials for tactile and sensory capabilities. Stratasys aims to enhance efficiency in product development, with both printers available for order, expected to ship in September and July 2021, respectively.
Stratasys Ltd. (NASDAQ: SSYS) has unveiled the J5 MediJet™ 3D printer, a versatile tool for healthcare providers and medical device companies. This printer features multi-material and multi-color capabilities, enabling the creation of detailed anatomical models and surgical guides. It is compact, cost-effective for small labs, and certified for sterilization and biocompatibility. The device is faster than competitors, and supports various materials, reducing the need for multiple printers. Stratasys aims to enhance patient care and expedite medical device innovation with this new technology.
Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer additive manufacturing, will participate in the Stifel Virtual Cross Sector Insight Conference on June 9, 2021, at 4:40 p.m. ET. The event will feature a live webcast, accessible through this link, and will also be archived for later viewing. Stratasys provides innovative 3D printing solutions across multiple industries, enhancing product design and manufacturing processes, showcasing their commitment to transforming operations.
Stratasys Ltd. (NASDAQ: SSYS) reported its first quarter 2021 results, with revenue of $134.2 million, up from $132.9 million in Q1 2020. GAAP net loss narrowed to $18.9 million ($0.32/share) from $21.7 million ($0.40/share) a year prior. Adjusted EBITDA turned positive at $3.5 million, compared to a negative $2.1 million. The company forecasted mid-teens percentage revenue growth for Q2 2021 and indicated that operating expenses could increase by $25-30 million for the full year due to staffing and acquisitions. CEO Dr. Yoav Zeif expressed confidence in future growth in the 3D printing sector.